bm 13505 has been researched along with prostaglandin h2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishii, A; Kishibayashi, N; Miki, I; Nonaka, H; Obase, H; Ohshima, E; Takami, H | 1 |
| Dellweg, H; Gross, R; Perzborn, E; Theis, JG | 1 |
| Aynedjian, HS; Bank, N | 1 |
| Lefer, AM; Smith, JB; Yanagisawa, A; Zipkin, R | 1 |
| Gresele, P; Mezzasoma, AM; Venditti, G; Vezza, R | 1 |
5 other study(ies) available for bm 13505 and prostaglandin h2
| Article | Year |
|---|---|
Effects of KW-3635, a novel dibenzoxepin derivative of a selective thromboxane A2 antagonist, on human, guinea pig and rat platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzimidazoles; Benzoxepins; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Guinea Pigs; Humans; Hydrazines; In Vitro Techniques; Kinetics; Prostaglandin Endoperoxides, Synthetic; Radioligand Assay; Rats; Receptors, Thromboxane; Species Specificity; Thromboxane A2; Tritium; Vasoconstrictor Agents | 1992 |
pH-dependent binding of the TXA2/PGH2-receptor of human platelet membranes to various ligands.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Blood Platelets; Carbazoles; Cell Membrane; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Ligands; Phenylacetates; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxanes; Vasoconstrictor Agents | 1992 |
Role of thromboxane in impaired renal vasodilatation response to acetylcholine in hypercholesterolemic rats.
Topics: Acetylcholine; Animals; Arginine; Calcium; Glomerular Filtration Rate; Hemodynamics; Hypercholesterolemia; Kidney; Nitric Oxide; Phenylacetates; Phospholipases A; Phospholipases A2; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Rats; Rats, Inbred Strains; Saralasin; Sulfonamides; Thromboxane A2; Vascular Resistance; Vasodilation | 1992 |
Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism.
Topics: Animals; Bicyclic Monoterpenes; Bridged Bicyclo Compounds, Heterocyclic; Cats; Coronary Vessels; Fatty Acids, Unsaturated; Hydrazines; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Sulfonamides; Thromboxane A2; Vasoconstriction | 1987 |
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Imidazoles; Inositol Phosphates; Kidney; Methacrylates; Phenylacetates; Platelet Activating Factor; Platelet Activation; Prostaglandin H2; Prostaglandins H; Protein Isoforms; Receptors, Thromboxane; Recombinant Fusion Proteins; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 2002 |